Q3 FY2026 · ended Sep 30, 2026 · Revenue $22.84M, +6.2% YoY · Filed Nov 3, 2026
Pulmonx Corporation (LUNG) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $22.8 million and a net loss of $8.4 million. Free cash flow was -$3.2 million. As of Sep 30, 2026 it held $52.7 million in cash and investments and $56.4 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- LUNG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1127537
- Former names
- PULMONX (until Feb 7, 2012)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $22.8M | $22.8M | $20.6M | $22.6M | $21.5M |
| Operating income | -$7.5M | -$9.1M | -$13.0M | -$9.9M | -$14.4M |
| Net income | -$8.4M | -$10.1M | -$13.7M | -$10.4M | -$14.0M |
| Diluted EPS | -$0.19 | -$0.24 | -$0.33 | -$0.25 | -$0.34 |
| Operating cash flow | -$3.2M | -$5.2M | -$10.1M | -$7.1M | -$8.2M |
| Free cash flow | -$3.2M | -$5.2M | -$10.1M | -$7.1M | -$8.3M |
| Total assets | $110.2M | $114.7M | $120.0M | $129.3M | $138.3M |
| Total liabilities | $76.0M | $75.5M | $74.2M | $75.2M | $78.2M |
| Stockholders' equity | $34.2M | $39.2M | $45.8M | $54.1M | $60.0M |
| Cash and investments | $52.7M | $55.8M | $61.6M | $69.8M | $76.5M |
| Total debt | $56.4M | $56.3M | $56.4M | $56.5M | $56.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 4, 2026 | Mar 31, 2026 |
All 450 Pulmonx Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.